Larvol Delta - Clearmind-Medicine-Announces-First-US-Clinical-Site-Initiation-for-CMND100-Clinical-Trial-in-Patients-with-Alcohol-Use-Disorder

5-methoxy-2-aminoindane (CMND-100) - Clearmind Medicine

https://www.globenewswire.com/news-release/2025/04/10/3059225/0/en/Clearmind-Medicine-Announces-First-U-S-Clinical-Site-Initiation-for-CMND-100-Clinical-Trial-in-Patients-with-Alcohol-Use-Disorder.html

Apr 10, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next